Boston Scientific has enjoyed success in the cardiac device space, but it continues to look to gain market share elsewhere, ...

Boston Scientific Corporation BSX is scheduled to report second-quarter 2024 results on Jul 24, before the opening bell. In the last reported quarter, the company’s earnings per share of 56 cents ...

17 deaths and 120 serious injuries have been reported due to complications during Watchman procedures. Boston Scientific warned Watchman customers of a higher risk of complications during procedures ...

Boston Scientific delivered strong first-quarter results, building on its hefty performance seen in 2024, as adoption of Farapulse and Watchman have impressed.

With the number of beats Boston Science Corp. has posted in recent years, it could be auditioning as a heavy metal drummer. Third quarter results kept up the streak, with overall sales 2% ahead of ...

Boston Scientific posted third-quarter operational top-line growth of 19%. Quarterly reported operating margin of 21% was supported by cardiovascular margin improvement of 260 basis points versus the ...